Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
AIM Vaccine Co., Ltd. Class H ( (HK:6660) ) has shared an update.
AIM Vaccine Co., Ltd. announced a change in its corporate structure with the resignation of Ms. Lam Wing Chi as Joint Company Secretary, Authorised Representative, and Process Agent, effective June 13, 2025. Ms. Wong Pui Kiu Ingrid has been appointed to these roles. The company expressed gratitude to Ms. Lam for her contributions and welcomed Ms. Wong, who brings over a decade of experience in corporate secretarial and legal advisory services. This change is part of an adjustment in work arrangements and is not due to any disagreements with the board.
More about AIM Vaccine Co., Ltd. Class H
AIM Vaccine Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the biopharmaceutical industry. The company, along with its subsidiaries, focuses on the development and production of vaccines.
Average Trading Volume: 2,017,313
Technical Sentiment Signal: Sell
See more insights into 6660 stock on TipRanks’ Stock Analysis page.